Jonathan F Anker (J Anker, Jonathan Anker)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Prostate Cancer

Transforming Growth Factor

Top Venues

Nature communications

Scientific reports

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan F Anker, Sumanta Kumar Pal, Seunghee Kim-Schulze, Huan Wang, Rebecca Halperin, Andrew Uzilov, Naoko Imai, Shingo Eikawa, Takuro Saito, Robert Sebra, Noah M Hahn, Manishkumar Patel, Jingjing Qi, Hui Xie, Nina Bhardwaj, Sacha Gnjatic, Matthew D Galsky
Antitumor immunity as the basis for durable disease-free treatment-free survival in patients with metastatic urothelial cancer. Journal for immunotherapy of cancer 11 (8) (2023)
R Vatapalli, V Sagar, Y Rodriguez, J C Zhao, K Unno, S Pamarthy, B Lysy, Jonathan F Anker, H Han, Y A Yoo, M Truica, Z R Chalmers, F Giles, Jindan Yu, Debabrata Chakravarti, B Carneiro, Sarki A Abdulkadir
Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. Nature communications 11 (1) (2020)
Young Kwang Chae, Jonathan F Anker, Michael S Oh, Preeti Bais, Sandeep Namburi, Sarita Agte, Francis J Giles, Jeffrey H Chuang
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma. Scientific reports 9 (1) (2019)
Jonathan F Anker, Anum F Naseem, Hanlin Mok, Anthony J Schaeffer, Sarki A Abdulkadir, Praveen Thumbikat
Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy. Nature communications 9 (1) (2018)